查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1475824

生命科學領域全球製造執行系統市場規模研究與預測，依解決方案類型、部署、最終用戶（製藥和生物技術公司、醫療器材公司等）和區域分析，2023-2030年

Global Manufacturing Execution System in Life Sciences Market Size Study & Forecast, By Solution Type By Deployment, By End-user (Pharmaceutical and Biotechnology Companies, Medical Device Companies, Others ) and Regional Analysis, 2023-2030
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 200 Pages | 商品交期: 2-3個工作天內

價格

2022年，全球生命科學製造執行系統市場價值約為24.7億美元，預計在2023-2030年預測期內將以超過12.20%的健康成長率成長。生命科學領域的製造執行系統（MES）是指基於軟體的解決方案，目的是管理和控制製藥、生物技術和醫療器材產業的製造流程。 MES 有助於即時監控、追蹤和執行製造操作，從原料準備到成品包裝。生物製藥行業的日益突出、技術進步的不斷進步以及製藥 4.0 的採用率上升，成為推動生命科學行業對製造執行系統（MES）需求的關鍵促進因素。製藥業擁抱數位轉型、推動製藥 4.0 以及生命科學市場中 MES 的採用興起。製藥 4.0 計畫目的是增強連接性、生產力、合規性和資訊管理，為產業挑戰提供更有效的解決方案。

製藥業日益數位化推動對 Pharma 4.0 的需求，這是生命科學領域製造執行系統市場擴張的重要因素。 Pharma 4.0 有助於提高連接性和生產力，同時簡化合規工作，並透過增強的生產資訊管理來快速回應新出現的問題。該模型透過培育更加以人為本的工作流程並更有效地連接工人，徹底改變了製造流程。國際製藥工程學會（ISPE）及其成員積極制定引進 Pharma 4.0 的路線圖，目的是幫助組織充分利用數位化的潛力，實現更快的治療創新和改進的生產流程，最終造福患者。 Pharma 4.0 生態系統內的主要利害關係人合作加速其採用。例如，2021年 3月，Lonza 和 NNIT 宣佈建立策略合作夥伴關係，目的是加速 MES 專案。此次合作將 Lonza 的 MODA 平台與 NNIT 的加速實施方法相整合，為組織提供全面的 Pharma 4.0 解決方案，並促進其加速數位化目標。因此，製藥 4.0 的日益普及推動了生命科學產業製造執行系統市場的成長。此外，生命科學產業的全球化和生物開發的嚴格監管要求為市場成長創造新的機會。然而，高昂的實施成本以及資料安全和隱私問題抑制了2023-2030年預測期內的市場成長。

生命科學市場全球製造執行系統研究涵蓋的關鍵區域包括亞太地區、北美、歐洲、拉丁美洲以及中東和非洲。由於技術進步和製藥行業製造流程的日益數位化是推動北美市場成長的關鍵因素，北美在2022年佔據主導地位。此外，市場受益於Emerson電氣公司和羅克韋爾自動化等有影響力的行業參與者的存在，它們為簡化醫療保健製造流程做出了重大貢獻。此外，整合實驗室自動化解決方案的採用為 MES 供應商提供了充滿希望的成長途徑。例如，Automata 計劃於2023年 2月在美國擴展其服務，這就是市場不斷擴大的機會的例證。由於生物技術產業的崛起、臨床試驗數量的增加以及政府對該地區生命科學產業的支持力度加大等因素，預計亞太地區在預測期內將出現顯著成長。

研究的目的是確定近年來不同細分市場和國家的市場規模，並預測未來幾年的價值。本報告目的是納入參與研究的國家內該行業的定性和定量方面。

本報告還提供了有關關鍵方面的詳細資訊，例如將決定市場未來成長的促進因素和挑戰。此外，它還納入了利害關係人投資的微觀市場的潛在機會，以及對主要參與者的競爭格局和產品供應的詳細分析。

目錄

第1章 執行摘要

  • 市場概況
  • 2020-2030年全球與細分市場估計與預測
    • 生命科學市場製造執行系統，依地區，2020-2030年
    • 生命科學市場製造執行系統，依解決方案類型，2020-2030年
    • 生命科學市場製造執行系統，依部署分類，2020-2030年
    • 生命科學市場製造執行系統，依最終用戶分類，2020-2030年
  • 主要趨勢
  • 估算方法
  • 研究假設

第2章 生命科學市場定義與範圍的全球製造執行系統

  • 研究目的
  • 市場定義和範圍
    • 產業演變
    • 研究範圍
  • 研究涵蓋的年份
  • 貨幣兌換率

第3章 生命科學市場動態中的全球製造執行系統

  • 生命科學市場影響分析中的製造執行系統（2020-2030）
    • 市場促進因素
      • 生物製藥產業的地位日益凸顯
      • 不斷進步的技術
      • 製藥 4.0 的採用率上升
    • 市場挑戰
      • 實施成本高
      • 資料安全和隱私問題
    • 市場機會
      • 生命科學產業全球化
      • 生物製品開發的嚴格監管要求

第4章 生命科學市場中的全球製造執行系統產業分析

  • 波特的五力模型
    • 供應商的議價能力
    • 買家的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭競爭
  • 波特的 5 力影響分析
  • PEST分析
    • 政治的
    • 經濟的
    • 社會的
    • 技術性
    • 環境的
    • 合法的
  • 頂級投資機會
  • 最佳制勝策略
  • COVID-19 影響分析
  • 顛覆性趨勢
  • 產業專家視角
  • 分析師推薦與結論

第5章 生命科學市場的全球製造執行系統，依解決方案類型

  • 市場概況
  • 生命科學市場中的全球製造執行系統，依解決方案類型，實績 - 潛力分析
  • 2020-2030年依解決方案類型分類的全球生命科學製造執行系統市場估計與預測
  • 生命科學市場的製造執行系統，細分分析
    • 軟體
    • 服務

第6章 生命科學市場中的全球製造執行系統，依部署

  • 市場概況
  • 生命科學市場中的全球製造執行系統，依部署，實績 - 潛力分析
  • 2020-2030年生命科學領域全球製造執行系統市場估計與預測，依部署
  • 生命科學市場的製造執行系統，細分分析
    • 本地部署
    • 基於雲端/網路
    • 混合

第7章 生命科學市場中的全球製造執行系統，依最終用戶

  • 市場概況
  • 生命科學市場中的全球製造執行系統，依最終用戶，實績 - 潛力分析
  • 2020-2030年依最終用戶全球生命科學製造執行系統市場估計與預測
  • 生命科學市場的製造執行系統，細分分析
    • 製藥和生物技術公司
    • 醫療器材公司
    • 其他（CDMO、CRO 等）

第8章 生命科學市場的全球製造執行系統，區域分析

  • 領先國家
  • 頂尖新興國家
  • 生命科學市場的製造執行系統，區域市場簡介
  • 北美洲
    • 美國
      • 2020-2030年解決方案類型細分估計與預測
      • 2020-2030年部署細分估計與預測
      • 2020-2030年最終用戶細分估計與預測
    • 加拿大
  • 歐洲生命科學製造執行系統市場概況
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 亞太生命科學製造執行系統市場概況
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲生命科學製造執行系統市場概況
    • 巴西
    • 墨西哥
  • 中東和非洲
    • 沙烏地阿拉伯
    • 南非
    • 中東和非洲其他地區

第9章 競爭情報

  • 重點企業SWOT分析
  • 頂級市場策略
  • 公司簡介
    • Korber AG
      • 關鍵訊息
      • 概述
      • 財務（視資料可用性而定）
      • 產品概要
      • 最近的發展
    • ABB Laboratories
    • MasterControl Solutions, Inc.
    • AVEVA Group Limited
    • Cognizant Technology Solutions Corporation
    • Rockwell Automation
    • Nagarro, Inc
    • Siemens AG
    • Emerson Electric Co.
    • iBase-t, Inc.

第10章 研究過程

  • 研究過程
    • 資料探勘
    • 分析
    • 市場預測
    • 驗證
    • 出版
  • 研究屬性
  • 研究假設

Global Manufacturing Execution System in Life Sciences Market is valued at approximately USD 2.47 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 12.20% over the forecast period 2023-2030. A Manufacturing Execution System (MES) in life sciences refers to a software-based solution designed to manage and control the manufacturing processes within the pharmaceutical, biotechnology, and medical device industries. MES facilitates the real-time monitoring, tracking, and execution of manufacturing operations, from raw material preparation to finished product packaging. The increasing prominence of the biopharmaceutical sector, rising technological advancements, and the rise in adoption of Pharma 4.0 stand out as key drivers fueling the demand for Manufacturing Execution Systems (MES) within the life sciences sector. The pharmaceutical industry embracing digital transformation, the push for Pharma 4.0, and the adoption of MES in the life sciences market are on the rise. Pharma 4.0 initiatives aim to bolster connectivity, productivity, compliance, and information management, enabling more effective solutions to industry challenges.

The increasing digitization within the pharmaceutical industry is driving the demand for Pharma 4.0, a significant factor contributing to the expansion of the manufacturing execution system market in the life sciences sector. Pharma 4.0 facilitates heightened connectivity and productivity while streamlining compliance efforts and enabling swift response to emerging issues through enhanced production information management. This model revolutionizes manufacturing processes by fostering more human-centric workflows and connecting workers more effectively. The International Society for Pharmaceutical Engineering (ISPE) and its members are actively developing a roadmap to introduce Pharma 4.0, aiming to empower organizations to harness the full potential of digitalization for faster therapeutic innovations and improved production processes, ultimately benefiting patients. Key stakeholders within the Pharma 4.0 ecosystem are collaborating to accelerate its adoption. For example, in March 2021, Lonza and NNIT announced a strategic partnership aimed at expediting MES projects. This collaboration integrates Lonza's MODA Platform with NNIT's Accelerated Implementation Methodology, providing organizations with a comprehensive Pharma 4.0 solution and facilitating the realization of their digitalization goals at an accelerated pace. Consequently, the increasing adoption of Pharma 4.0 drives the growth of the Manufacturing Execution System Market in The Life Sciences Industry. In addition, the globalization of the life sciences industry and stringent regulatory requirements for biological development are creating new opportunities for market growth. However, the high implementation cost and data security and privacy concerns stifle market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Manufacturing Execution System in Life Sciences Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to technological advancements and the increasing digitization of manufacturing processes within the pharmaceutical industry are key factors propelling market growth in North America. Furthermore, the market benefits from the presence of influential industry players like Emerson Electric Co. and Rockwell Automation, which contribute significantly to streamlining healthcare manufacturing processes. Additionally, the adoption of integrated laboratory automation solutions presents promising growth avenues for MES providers. For instance, Automata's plans to expand its services in the U.S. in February 2023 exemplify the market's expanding opportunities. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as the rising biotechnology industry, rising number of clinical trials, and rising government support for the life science industry in the region.

Major market players included in this report are:

  • Korber AG
  • ABB Laboratories
  • MasterControl Solutions, Inc.
  • AVEVA Group Limited
  • Cognizant Technology Solutions Corporation
  • Rockwell Automation
  • Nagarro, Inc.
  • Siemens AG
  • Emerson Electric Co.
  • iBase-t, Inc.

Recent Developments in the Market:

  • In January 2024, CGI Inc. and Korber AG joined hands to provide an integrated solution tailored to optimize production processes for pharmaceutical and life sciences firms. By merging CGI's end-to-end Solution Types with Korber's Werum PAS-X MES Suite, the partnership endeavours to enhance accuracy, efficiency, and safety throughout the pharmaceutical product development cycle. Additionally, clients gain access to real-time data, empowering them to make informed decisions and elevate overall operational performance.
  • In February 2023, AVEVA Group Limited, a leading industrial software provider, unveiled its latest offering: the AVEVA Manufacturing Execution System. This updated release is designed to streamline the deployment of multi-site MES solutions while mitigating associated costs and complexities. With its enhanced version, AVEVA MES facilitates quicker and more efficient adoption of industry best practices, ultimately driving operational efficiency and sustainability improvements.

Global Manufacturing Execution System in Life Sciences Market Report Scope:

  • Historical Data - 2020 - 2021
  • Base Year for Estimation - 2022
  • Forecast period - 2023-2030
  • Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered - Solution Type, Deployment, End-user, Region
  • Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope - Free report customization (equivalent to up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters to detailed information about the crucial aspects such as driving factors & challenges that will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Solution Type:

  • Software
  • Services

By Deployment:

  • On-Premise
  • Cloud/Web-Based
  • Hybrid

By End-user:

  • Pharmaceutical and Biotechnology Companies
  • Medical Device Companies
  • Others (CDMOs, CROs, etc.)

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1.Executive Summary

  • 1.1.Market Snapshot
  • 1.2.Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1.Manufacturing Execution System in Life Sciences Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2.Manufacturing Execution System in Life Sciences Market, by Solution Type, 2020-2030 (USD Billion)
    • 1.2.3.Manufacturing Execution System in Life Sciences Market, by Deployment, 2020-2030 (USD Billion)
    • 1.2.4.Manufacturing Execution System in Life Sciences Market, by End-user, 2020-2030 (USD Billion)
  • 1.3.Key Trends
  • 1.4.Estimation Methodology
  • 1.5.Research Assumption

Chapter 2.Global Manufacturing Execution System in Life Sciences Market Definition and Scope

  • 2.1.Objective of the Study
  • 2.2.Market Definition & Scope
    • 2.2.1.Industry Evolution
    • 2.2.2.Scope of the Study
  • 2.3.Years Considered for the Study
  • 2.4.Currency Conversion Rates

Chapter 3.Global Manufacturing Execution System in Life Sciences Market Dynamics

  • 3.1.Manufacturing Execution System in Life Sciences Market Impact Analysis (2020-2030)
    • 3.1.1.Market Drivers
      • 3.1.1.1.Increasing Prominence of Biopharmaceutical Sector
      • 3.1.1.2.Rising Technological Advancements
      • 3.1.1.3.Rise in Adoption of Pharma 4.0
    • 3.1.2.Market Challenges
      • 3.1.2.1.High Implementation Cost
      • 3.1.2.2.Data Security and Privacy Concerns
    • 3.1.3.Market Opportunities
      • 3.1.3.1.Globalization of Life Sciences Industry
      • 3.1.3.2.Stringent Regulatory Requirements for Biologicals Development

Chapter 4.Global Manufacturing Execution System in Life Sciences Market Industry Analysis

  • 4.1.Porter's 5 Force Model
    • 4.1.1.Bargaining Power of Suppliers
    • 4.1.2.Bargaining Power of Buyers
    • 4.1.3.Threat of New Entrants
    • 4.1.4.Threat of Substitutes
    • 4.1.5.Competitive Rivalry
  • 4.2.Porter's 5 Force Impact Analysis
  • 4.3.PEST Analysis
    • 4.3.1.Political
    • 4.3.2.Economical
    • 4.3.3.Social
    • 4.3.4.Technological
    • 4.3.5.Environmental
    • 4.3.6.Legal
  • 4.4.Top investment opportunity
  • 4.5.Top winning strategies
  • 4.6.COVID-19 Impact Analysis
  • 4.7.Disruptive Trends
  • 4.8.Industry Expert Perspective
  • 4.9.Analyst Recommendation & Conclusion

Chapter 5.Global Manufacturing Execution System in Life Sciences Market, by Solution Type

  • 5.1.Market Snapshot
  • 5.2.Global Manufacturing Execution System in Life Sciences Market by Solution Type, Performance - Potential Analysis
  • 5.3.Global Manufacturing Execution System in Life Sciences Market Estimates & Forecasts by Solution Type 2020-2030 (USD Billion)
  • 5.4.Manufacturing Execution System in Life Sciences Market, Sub Segment Analysis
    • 5.4.1. Software
    • 5.4.2.Services

Chapter 6.Global Manufacturing Execution System in Life Sciences Market, by Deployment

  • 6.1.Market Snapshot
  • 6.2.Global Manufacturing Execution System in Life Sciences Market by Deployment, Performance - Potential Analysis
  • 6.3.Global Manufacturing Execution System in Life Sciences Market Estimates & Forecasts by Deployment 2020-2030 (USD Billion)
  • 6.4.Manufacturing Execution System in Life Sciences Market, Sub Segment Analysis
    • 6.4.1. On-Premise
    • 6.4.2.Cloud/Web-Based
    • 6.4.3.Hybrid

Chapter 7.Global Manufacturing Execution System in Life Sciences Market, by End-user

  • 7.1.Market Snapshot
  • 7.2.Global Manufacturing Execution System in Life Sciences Market by End-user, Performance - Potential Analysis
  • 7.3.Global Manufacturing Execution System in Life Sciences Market Estimates & Forecasts by End-user 2020-2030 (USD Billion)
  • 7.4.Manufacturing Execution System in Life Sciences Market, Sub Segment Analysis
    • 7.4.1. Pharmaceutical and Biotechnology Companies
    • 7.4.2.Medical Device Companies
    • 7.4.3.Others (CDMOs, CROs, etc.)

Chapter 8.Global Manufacturing Execution System in Life Sciences Market, Regional Analysis

  • 8.1.Top Leading Countries
  • 8.2.Top Emerging Countries
  • 8.3.Manufacturing Execution System in Life Sciences Market, Regional Market Snapshot
  • 8.4.North America Manufacturing Execution System in Life Sciences Market
    • 8.4.1.U.S. Manufacturing Execution System in Life Sciences Market
      • 8.4.1.1.Solution Type breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2.Deployment breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3.End-user breakdown estimates & forecasts, 2020-2030
    • 8.4.2.Canada Manufacturing Execution System in Life Sciences Market
  • 8.5.Europe Manufacturing Execution System in Life Sciences Market Snapshot
    • 8.5.1.U.K. Manufacturing Execution System in Life Sciences Market
    • 8.5.2.Germany Manufacturing Execution System in Life Sciences Market
    • 8.5.3.France Manufacturing Execution System in Life Sciences Market
    • 8.5.4.Spain Manufacturing Execution System in Life Sciences Market
    • 8.5.5.Italy Manufacturing Execution System in Life Sciences Market
    • 8.5.6.Rest of Europe Manufacturing Execution System in Life Sciences Market
  • 8.6.Asia-Pacific Manufacturing Execution System in Life Sciences Market Snapshot
    • 8.6.1.China Manufacturing Execution System in Life Sciences Market
    • 8.6.2.India Manufacturing Execution System in Life Sciences Market
    • 8.6.3.Japan Manufacturing Execution System in Life Sciences Market
    • 8.6.4.Australia Manufacturing Execution System in Life Sciences Market
    • 8.6.5.South Korea Manufacturing Execution System in Life Sciences Market
    • 8.6.6.Rest of Asia Pacific Manufacturing Execution System in Life Sciences Market
  • 8.7.Latin America Manufacturing Execution System in Life Sciences Market Snapshot
    • 8.7.1.Brazil Manufacturing Execution System in Life Sciences Market
    • 8.7.2.Mexico Manufacturing Execution System in Life Sciences Market
  • 8.8.Middle East & Africa Manufacturing Execution System in Life Sciences Market
    • 8.8.1.Saudi Arabia Manufacturing Execution System in Life Sciences Market
    • 8.8.2.South Africa Manufacturing Execution System in Life Sciences Market
    • 8.8.3.Rest of Middle East & Africa Manufacturing Execution System in Life Sciences Market

Chapter 9.Competitive Intelligence

  • 9.1.Key Company SWOT Analysis
  • 9.2.Top Market Strategies
  • 9.3.Company Profiles
    • 9.3.1. Korber AG
      • 9.3.1.1.Key Information
      • 9.3.1.2.Overview
      • 9.3.1.3.Financial (Subject to Data Availability)
      • 9.3.1.4.Product Summary
      • 9.3.1.5.Recent Developments
    • 9.3.2. ABB Laboratories
    • 9.3.3.MasterControl Solutions, Inc.
    • 9.3.4.AVEVA Group Limited
    • 9.3.5.Cognizant Technology Solutions Corporation
    • 9.3.6.Rockwell Automation
    • 9.3.7.Nagarro, Inc
    • 9.3.8.Siemens AG
    • 9.3.9.Emerson Electric Co.
    • 9.3.10.iBase-t, Inc.

Chapter 10.Research Process

  • 10.1.Research Process
    • 10.1.1.Data Mining
    • 10.1.2.Analysis
    • 10.1.3.Market Estimation
    • 10.1.4.Validation
    • 10.1.5.Publishing
  • 10.2.Research Attributes
  • 10.3.Research Assumption

LIST OF TABLES

  • TABLE 1.Global Manufacturing Execution System in Life Sciences Market, report scope
  • TABLE 2.Global Manufacturing Execution System in Life Sciences Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3.Global Manufacturing Execution System in Life Sciences Market estimates & forecasts by Solution Type 2020-2030 (USD Billion)
  • TABLE 4.Global Manufacturing Execution System in Life Sciences Market estimates & forecasts by Deployment 2020-2030 (USD Billion)
  • TABLE 5.Global Manufacturing Execution System in Life Sciences Market estimates & forecasts by End-user 2020-2030 (USD Billion)
  • TABLE 6.Global Manufacturing Execution System in Life Sciences Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7.Global Manufacturing Execution System in Life Sciences Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8.Global Manufacturing Execution System in Life Sciences Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9.Global Manufacturing Execution System in Life Sciences Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10.Global Manufacturing Execution System in Life Sciences Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11.Global Manufacturing Execution System in Life Sciences Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12.Global Manufacturing Execution System in Life Sciences Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13.Global Manufacturing Execution System in Life Sciences Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14.Global Manufacturing Execution System in Life Sciences Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15.Global Manufacturing Execution System in Life Sciences Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16.U.S. Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 17.U.S. Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18.U.S. Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 19.Canada Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 20.Canada Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21.Canada Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 22.UK Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 23.UK Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24.UK Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 25.Germany Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 26.Germany Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27.Germany Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 28.France Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 29.France Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30.France Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 31.Italy Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 32.Italy Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33.Italy Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 34.Spain Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 35.Spain Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36.Spain Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 37.RoE Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 38.RoE Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39.RoE Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 40.China Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 41.China Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42.China Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 43.India Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 44.India Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45.India Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 46.Japan Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 47.Japan Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48.Japan Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 49.South Korea Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 50.South Korea Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51.South Korea Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 52.Australia Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 53.Australia Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54.Australia Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 55.RoAPAC Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 56.RoAPAC Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57.RoAPAC Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 58.Brazil Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 59.Brazil Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60.Brazil Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 61.Mexico Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 62.Mexico Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63.Mexico Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 64.RoLA Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 65.RoLA Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66.RoLA Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 67.Saudi Arabia Manufacturing Execution System in Life Sciences Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 68.South Africa Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69.RoMEA Manufacturing Execution System in Life Sciences Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 70.List of secondary sources, used in the study of Global Manufacturing Execution System in Life Sciences Market
  • TABLE 71.List of primary sources, used in the study of Global Manufacturing Execution System in Life Sciences Market
  • TABLE 72.Years considered for the study
  • TABLE 73.Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1.Global Manufacturing Execution System in Life Sciences Market, research methodology
  • FIG 2.Global Manufacturing Execution System in Life Sciences Market, Market estimation techniques
  • FIG 3.Global Market size estimates & forecast methods
  • FIG 4.Global Manufacturing Execution System in Life Sciences Market, key trends 2022
  • FIG 5.Global Manufacturing Execution System in Life Sciences Market, growth prospects 2023-2030
  • FIG 6.Global Manufacturing Execution System in Life Sciences Market, porters 5 force model
  • FIG 7.Global Manufacturing Execution System in Life Sciences Market, pest analysis
  • FIG 8.Global Manufacturing Execution System in Life Sciences Market, value chain analysis
  • FIG 9.Global Manufacturing Execution System in Life Sciences Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10.Global Manufacturing Execution System in Life Sciences Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11.Global Manufacturing Execution System in Life Sciences Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12.Global Manufacturing Execution System in Life Sciences Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13.Global Manufacturing Execution System in Life Sciences Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14.Global Manufacturing Execution System in Life Sciences Market, regional snapshot 2020 & 2030
  • FIG 15.North America Manufacturing Execution System in Life Sciences Market 2020 & 2030 (USD Billion)
  • FIG 16.Europe Manufacturing Execution System in Life Sciences Market 2020 & 2030 (USD Billion)
  • FIG 17.Asia Pacific Manufacturing Execution System in Life Sciences Market 2020 & 2030 (USD Billion)
  • FIG 18.Latin America Manufacturing Execution System in Life Sciences Market 2020 & 2030 (USD Billion)
  • FIG 19.Middle East & Africa Manufacturing Execution System in Life Sciences Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable